Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001662252-16-000212
Filing Date
2016-08-22
Accepted
2016-08-22 16:08:23
Documents
60
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-K rcha10k.htm 10-K 949357
2 EX-31 ex31.htm EX-31 11217
3 EX-32 ex32.htm EX-32 3832
4 GRAPHIC image_001.gif GRAPHIC 9001
  Complete submission text file 0001662252-16-000212.txt   5379719

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rcha-20160331.xml EX-101.INS 1135242
6 XBRL SCHEMA FILE rcha-20160331.xsd EX-101.SCH 67923
7 XBRL CALCULATION FILE rcha-20160331_cal.xml EX-101.CAL 33971
8 XBRL DEFINITION FILE rcha-20160331_def.xml EX-101.DEF 171266
9 XBRL LABEL FILE rcha-20160331_lab.xml EX-101.LAB 291093
10 XBRL PRESENTATION FILE rcha-20160331_pre.xml EX-101.PRE 264683
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-54767 | Film No.: 161845377
SIC: 2834 Pharmaceutical Preparations